In human endothelial cells, quercetin or its metabolite isorhamnetin inhibit the expression of biomarkers of endothelial dysfunction including VCAM-1, ICAM-1 and MCP-1 at a physiologically attainable concentration of 2 μM [121]. This evidence concerns the gene ICAM1 and endothelial dysfunction.